NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nusano

Nusano

Private
West Valley City, UtahHealthcare & Life Scienceshttps://nusano.com/

Last Round

Series C

Oct 1, 2024

Est. Valuation

$208.31M

Total Funding Raised

$265.65M

Company Overview

Nusano is a medical technology company that develops advanced ion sources and linear accelerators to enhance radioisotope manufacturing for medical and industrial applications.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Biotechnology, Advanced Materials, Medical Imaging, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

radioisotope productionmedical radioisotopesisotope manufacturingradiopharmaceuticalsLutetium-177Actinium-225linear acceleratorradioligand therapyparticle accelerationnuclear medicinetheranosticsdomestic supply chainindustrial radioisotopesisotope supplierradiochemistry servicesstable isotope enrichment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nusano Comps

Public and private peers based on sector, stage, and business model.

Nusano comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nusano Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series COct 1, 2024
Series BNov 1, 2022
Series BSep 8, 2021
SeedOct 24, 2018
SeedOct 23, 2017

Key People

Founding team and executive leadership

Chris Lowe

Chief Executive Officer

Executive Team

Pushkar Bedekar

Chief Financial Officer

Executive Team

Kevin Haehl

Chief Product Officer

Executive Team

Nusano Investors

Notable investors and investment history

Nusano investors
InvestorRounds
S32Series C
BrightEdgeSeries C, Series B
Wasatch Equity PartnersSeries B, Series C
BrightEdgeSeries B
Wasatch Venture PartnersSeries C
Casdin CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 11, 2025

    Received 'Best Companies to Work For' Award from Utah Business.

  • Nov 12, 2025

    Team members attended the Utah Life Sciences Summit on November 12, 2025.

Nusano Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nusano Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nusano's valuation, stock price, and market status.

Firmographic Details

HeadquartersWest Valley City, Utah
Employee Range173
Year Founded2016
Last FundingOct 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.